Rating History for AN2 Therapeutics (ANTX) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for ANTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/20/2026 Brad Canino New Coverage Buy
(N/A)		 9.00
(N/A)		 4.67
(4.79)		 2.57% Details